On July 7, 2026, Jana Medical Company announced that its Board of Directors approved the formation of the Audit Committee for the current Board term, which runs from July 28, 2022 to July 27, 2026. The committee comprises three external members: Mr. Ahmed Mohammed Al Farraj (Chairman), a Certified Public Accountant with over 23 years of experience in auditing and financial management; Mr. Fawaz Qaed Alanazi (Member), an internal audit and governance expert with over 20 years of experience; and Mr. Muslat Manahi Almarzoqi (Member), a finance and executive management professional with over 25 years of experience. All appointments are effective from the date of the Board resolution and will remain in effect until the end of the current Board term.

Original announcement:

Note: The original announcement does not explicitly specify a currency unit. Figures above are reproduced as-is. Please refer to the original announcement for details.

Important Notice: The announcement information and market data in this report are sourced directly from the Saudi Exchange (Tadawul). This summary is generated by Sahm’s proprietary AI model for informational purposes only. While we strive for accuracy, it should not be construed as financial advice or an investment recommendation.